Document Detail


Polycystic ovary syndrome and metformin in pregnancy.
MedLine Citation:
PMID:  16817087     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: So far, evidence for safety of continued therapy throughout gestation is insufficient, and existing papers are limited in design and might mask for fetal toxic outcomes due to metformin therapy. Prior to a recommendation of sustained metformin therapy throughout pregnancy, randomized placebo-controlled double-blinded clinical trials are awaited with interest, so that present assumptions on efficiency can be clarified, in order to assure efficient and safe management of pregnant polycystic ovary syndrome patients.
Authors:
Anna E Lilja; Elisabeth R Mathiesen
Related Documents :
3780307 - Pigmentary demarcation lines during pregnancy.
20537747 - A quantitative evaluation of total antioxidant status and oxidative stress markers in p...
24663107 - Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic ...
569047 - Defects of the central nervous system in finland: iii. disease and drugs in pregnancy.
8819997 - Comparative study of lactoferrin and other blood markers of inflammatory stress between...
7481937 - Acceptability of prenatal diagnosis of sickle cell anaemia (sca) by female patients and...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  85     ISSN:  0001-6349     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2006  
Date Detail:
Created Date:  2006-07-03     Completed Date:  2006-08-16     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  861-8     Citation Subset:  IM    
Affiliation:
Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark. annalilja@stud.ku.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Administration Schedule
Female
Humans
Metformin / administration & dosage*,  adverse effects
Ovulation Induction*
Polycystic Ovary Syndrome / drug therapy*
Pregnancy
Pregnancy Complications / prevention & control*
Chemical
Reg. No./Substance:
657-24-9/Metformin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of mediolateral episiotomy during labour: analysis of risk factors for obstetric anal sphin...
Next Document:  Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in wome...